Related Experiment Video
Updated: Jun 4, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
p85alpha regulates osteoblast differentiation by cross-talking with the MAPK pathway
Xiaohua Wu1, Shi Chen, Selina A Orlando
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Abstract:
Class IA phosphoinositide 3-kinase (PI3K) is involved in regulating many cellular functions including cell growth, proliferation, cell survival, and differentiation. The p85 regulatory subunit is a critical component of the PI3K signaling pathway. Mesenchymal stem cells (MSC) are multipotent cells that can be differentiated into osteoblasts (OBs), adipocytes, and chondrocytes under defined culture conditions. To determine whether p85α subunit of PI3K affects biological functions of MSCs, bone marrow-derived wild type (WT) and p85α-deficient (p85α(-/-)) cells were employed in this study. Increased cell growth, higher proliferation rate and reduced number of senescent cells were observed in MSCs lacking p85α compare with WT MSCs as evaluated by CFU-F assay, thymidine incorporation assay, and β-galactosidase staining, respectively. These functional changes are associated with the increased cell cycle, increased expression of cyclin D, cyclin E, and reduced expression of p16 and p19 in p85α(-/-) MSCs. In addition, a time-dependent reduction in alkaline phosphatase (ALP) activity and osteocalcin mRNA expression was observed in p85α(-/-) MSCs compared with WT MSCs, suggesting impaired osteoblast differentiation due to p85α deficiency in MSCs. The impaired p85α(-/-) osteoblast differentiation was associated with increased activation of Akt and MAPK. Importantly, bone morphogenic protein 2 (BMP2) was able to intensify the differentiation of osteoblasts derived from WT MSCs, whereas this process was significantly impaired as a result of p85α deficiency. Addition of LY294002, a PI3K inhibitor, did not alter the differentiation of osteoblasts in either genotype. However, application of PD98059, a Mek/MAPK inhibitor, significantly enhanced osteoblast differentiation in WT and p85α(-/-) MSCs. These results suggest that p85α plays an essential role in osteoblast differentiation from MSCs by repressing the activation of MAPK pathway.
Insights
The p85α subunit of phosphoinositide 3-kinase (PI3K) is crucial for mesenchymal stem cell (MSC) osteoblast differentiation. Its absence impairs differentiation by increasing MAPK pathway activation, hindering bone formation.
Area of Science:
- Cellular Biology
- Stem Cell Research
- Molecular Signaling
Background:
- Class IA phosphoinositide 3-kinase (PI3K) regulates critical cellular functions.
- The p85 regulatory subunit is a key component of the PI3K pathway.
- Mesenchymal stem cells (MSCs) differentiate into osteoblasts, adipocytes, and chondrocytes.
Purpose of the Study:
- To investigate the role of the p85α subunit of PI3K in regulating MSC biological functions.
- To determine the impact of p85α deficiency on osteoblast differentiation from MSCs.
Main Methods:
- Comparison of wild-type (WT) and p85α-deficient (p85α(-/-)) bone marrow-derived MSCs.
- Assays included CFU-F, thymidine incorporation, β-galactosidase staining, ALP activity, and osteocalcin mRNA expression.
- Analysis of cell cycle regulators, Akt, MAPK pathways, and response to BMP2, LY294002, and PD98059.
Main Results:
- p85α deficiency in MSCs increased cell growth, proliferation, and cell cycle progression, while reducing senescence.
- Osteoblast differentiation was impaired in p85α(-/-) MSCs, evidenced by reduced ALP activity and osteocalcin expression.
- p85α deficiency led to increased Akt and MAPK activation; MAPK inhibition enhanced osteoblast differentiation in both genotypes.
Conclusions:
- The p85α subunit of PI3K is essential for normal osteoblast differentiation from MSCs.
- p85α deficiency impairs osteogenesis by derepressing MAPK pathway activation.
- Targeting the MAPK pathway may offer therapeutic strategies for bone regeneration.
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Master Transcription Regulators
Osteoclasts in Bone Remodeling
PI3K/mTOR/AKT Signaling Pathway